Skip Navigation

This Article
Right arrow Abstract
Right arrow FREE Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow Request Permissions

Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome
J. Natl. Cancer Inst. Winnepenninckx et al. 98: 472

Supplementary Tables

The following supplementary tables accompany this Article:

Files in this Data Supplement:

  • Supplementary Table 1 - List of 361 sequences discriminating between melanomas associated with distant metastasis free-survival (DMFS) of less than or equal to 4 years or more than 4 years (adjusted P<.05; any adjusted P value less than .05 was considered statistically significant). Raw_p = nonadjusted P value for t test comparing the average expressions between the two groups; fdr_p = P value adjusted for the false discovery rate; mean0 = average log ratio of the expressions of the primary tumors in the good prognosis group (M–), compared with the reference pool; std0 = standard deviation of these log ratio values; mean1 = average log ratio of the expressions of the primary tumors in the poor prognosis group (M+), compared with to the reference pool; std1 = standard deviation of these log ratio values; Agilent_accession: Agilent accession number; probe = Agilent oligonucleotide reference; accession = gene code in the data base (LocusLink,GeneBank); gene_symbol = gene symbol in LocusLink database; description = gene description in LocusLink database; location = gene chromosomal location in LocusLink database. All statistical tests were two-sided.
  • Supplementary Table 2 - Correlation between sequences and thickness (adjusted P<.05). Correl = Pearson correlation value between the log ratio of the primary tumors expressions, compared with the reference pool and the corresponding thicknesses; raw_p = nonadjusted P value for test of significance of the Pearson correlation value; fdr_p = P value adjusted for the false discovery rate; Agilent_accession: Agilent accession number; probe = Agilent oligonucleotide reference; accession = gene code in the data base (LocusLink,GeneBank); gene_symbol = gene symbol in LocusLink database; description = gene description in LocusLink database; location = gene chromosomal location in LocusLink database. All statistical tests were two-sided.
  • Supplementary Table 3 - List of 254 sequences discriminating between melanomas associated with distant metastasis free-survival (DMFS) of less than or equal to 4 years or more than 4 years used in the prediction rule. Order = order of importance as determined by P value; Agilent_accession: Agilent accession number; accession = gene code in the data base (LocusLink,GeneBank); gene_symbol = gene symbol in LocusLink database; direction = relative expression in melanomas in group M+ vs. group M–, as shown by the oligonucleotide microarray data; involvement in melanoma = references from PubMed publications; involvement in non-melanoma cancer = type of cancer and references from PubMed publications.




This Article
Right arrow Abstract
Right arrow FREE Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow Request Permissions